Active Surveillance Prostate Cancer Video Chat, May 13th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Blue Earth Diagnostics, and Foundation Medicine.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
Eric- Atlanta 8:29 PM
BPH ASPI video Dr. Casey Dauw: https://aspatients.org/meeting/the-abcs-of-bph/
Eric- Atlanta 8:30 PM
Ancan Special Presentation: It Ain’t Your Grandpa’s BPH: https://ancan.org/special-presentation-it-aint-your-grandpas-bph/
Andy Douglas, FL 8:40 PM
Standard Medicare Coverage Criteria (all must be met) Medicare covers Aquablation once per patient when: prostate volume is 30–150 cc confirmed by transrectal ultrasound (TRUS), IPSS score greater than or equal to 12, maximum urinary flow rate less than or equal to15 mL/s with voided volume greater than 125 cc, and there has been failure or intolerance of at least 3 months of conventional therapy (such as alpha-blockers or 5-ARIs). The procedure must use an FDA-approved device
Rob Wood 8:42 PM
Rob Wood – Maine– aquablation questions to Mike Williams woodsinmaine@gmail.com
BJ Kap 8:59 PM
thanks guys great discussion have a good night
Eric- Atlanta 9:10 PM
Benign Prostatic Hypertrophy (BPH) Morgan McDowell, DNP, APRN, WHNP-BC, AGPCNP-BC: https://grandroundsinurology.com/benign-prostatic-hypertrophy-bph/?_hsmi=381422106&fbclid=IwZXh0bgNhZW0CMTEAc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHicfwgnaFklEBjKzeyZafooENJ-llAD_2V-GZKdLpAKoPZvT4jXRibNOyO-y_aem_x0ohp35PKH7dhukcwFD2Tg
Mike Thompson 9:15 PM
Thanks everyone- great discussion tonight. Good night.
Predicting Radiation Side Effects – PROSTOX Webinar with interesting updates!
Last year, we presented a webinar on predicting Prostate Cancer Radiation Treatment side effects with PROSTOX before treatment begins. By analyzing your unique genetics, you can make smarter, more informed decisions to avoid side effects and safeguard your quality of life for years to come.
PROSTOX Standard (previously PROSTOX CFRT+) predicts late grade ≥2 toxicity from conventionally fractionated (CFRT) or moderately hypofractionated (MHFRT) radiation therapy for patients with localized prostate cancer. Together with PROSTOX Ultra, which is already available for patients considering stereotactic body radiation therapy (SBRT), the PROSTOX portfolio now provides risk assessment across a broader range of external beam radiation therapy (EBRT) types. We’ll discuss the updates and other patient concerns, such as insurance coverage and questions to bring to your doctors.
Active Surveillance Prostate Cancer Video Chat, April 22nd, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
Active Surveillance Prostate Cancer Video Chat, April 8th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
Eric- Atlanta 8:00 PM
2026 Prostate Cancer Patients and Caregivers Conference September 18th-20th, 2026 | Early Registration | $30 https://pcri.org/2026-conference
Phil-Toronto 8:03 PM
PCRI mid-year update April 25/26
Ron Jr (Sharon, Pa) 8:28 PM
I live in the Rust Belt, NW Pa, country area – and my Urologist only does Trans-perineal biopsy. I had a hip replacement & it’s the ONLY biopsy I had, and I will get moving forward. Infection would put my total hip at risk!
Albert 9:01 PM
thanks all. Bye, Albert
AnCan – Rick 9:04 PM
Turkey bacon ain’t so bad
AnCan – Rick 9:06 PM
PCPEP study – sign up! https://ancan.org/pcpep-the-prostate-cancer-patient-empowerment-program-040126/
Eric- Atlanta 9:07 PM
Is the PCPEP seminar shared? I had to miss.
PCPEP – The Prostate Cancer Patient Empowerment Program: Improve Your Quality of Life
PCPEP – learn how to employ the Science and Practice of an Anti‑Inflammatory Lifestyle – With Dr. Rob Rutledge
AnCan is all about survivorship – improving Quality of Life after diagnosis, with a focus on diet/nutrition, exercise, stress management, and more.
We now welcome PCPEP (Prostate Cancer Patient Empowerment Program), a Canadian-based program at Dalhousie University in Halifax, Nova Scotia. https://pcpep.org to our AnCan family.
PCPEP’s goal is to optimize survivorship for prostate cancer patients and others. It does this through daily emails and videos focused on components that contribute to your QoL – exercise, nutrition, stress reduction, and the social connection that makes AnCan a big family.
Watch Co-founder Dr. Rob Rutledge, a GU radiation oncologist, explain the program.
The program is FREE and currently open to ALL men with a prostate cancer diagnosis. Although the presentation was made to Gents in early Active Surveillance, it is open to all levels.
